KUALA LUMPUR, July 20 (Bernama) -- MedTech Innovator, the largest accelerator of medical technology companies in the world, in partnership with Asia Pacific Medical Technology Association (APACMed), has selected 20 companies to participate in the organisation’s third annual Asia Pacific Accelerator programme.
The companies, among others, are 4baseCare; AEvice Health; Alimetry; Bioscan Research; Cell4D; DC Medical; ErleaDx; and, Lenexa Medical.
In a statement, the company said that the MedTech Innovator Asia Pacific offers best-in-class start-ups with opportunities to work with investors, business leaders and allied service professionals in the medical technology industry to help drive the commercialisation of life-changing technologies throughout the region.
The 2022 cohort companies will also compete for up to US$300,000 (US$1=RM4.447) in cash prizes and awards.
“This year’s selected cohorts for our Asia Pacific Accelerator programme represent some of the region’s most promising entrepreneurs looking to solve significant real-world problems in healthcare.
“Together with our sponsors, we look forward to helping them bring their innovations to patients in need,” said MedTech Innovator chief executive officer Paul Grand.
Over 250 companies applied for the Asia Pacific programme, but only four startups from the 2022 Asia Pacific cohort will advance to compete in the grand finals at APACMed’s Medtech Forum 2022 in Singapore, which runs from September 26-27, 2022.
Attended by healthcare industry leaders, healthcare providers, and investors from across the region, the MedTech Forum will also showcase solutions from the 20 accelerator companies.
The winning company, which will be determined by audience vote, stands to win a non-dilutive cash prize and the title of the 2022 MedTech Innovator Asia Pacific Winner.
-- BERNAMA
No comments:
Post a Comment